Pediatric Cancer

PEDIATRIC CANCER ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

Does Larotrectinib Offer New Hope to Children With TRK Fusion-Positive Solid Tumors?

Because of the drug’s promising safety and efficacy, the first child was treated on trial only 9 months after the first adult with a TRK fusion was treated.
Recent Conference Highlights New Potential Targets for Pediatric Cancer Treatments

Advances in targeted therapy for pediatric patients were presented at the AACR Special Conference on Pediatric Cancer.

PEDIATRIC CANCER NEWS

Childhood cancer survivors exposed to therapies that cause pulmonary dysfunction are associated with

Coronary Artery Disease Risk Down in Survivors of Childhood Cancer

January 17, 2020

Population-wide care ought to be optimal, regardless of region, argue the authors of a recent study.

Next-Gen Sequencing Found to Predict Bloodstream Infections in Children

January 6, 2020

Fertility Treatment and Childhood Cancer Risk: What’s the Link?

January 6, 2020

Childhood cancer survivors exposed to therapies that cause pulmonary dysfunction are associated with

Survivors of Childhood Cancers at Risk for Shortened Life Span

January 3, 2020

The increased prevalence may be real, or it could be the result of the detection of more harmless tumors through increased screening efforts.

Pediatric Thyroid Cancer Rates Are Rising, but Some Experts Doubt the Significance

July 9, 2019

Next post in Pediatric Cancer

Long-Term Follow-Up for Late Effects in Survivors of Childhood and Adolescent/Young Adult Cancers

Overall Cancer Survival Rates Up Among Adolescents, Young Adults